Drug induced oesophageal injury is an important and preventable cause of iatrogenic injury. In most cases the injury is considered to be due to mucosal contact from formulations lodged in the oesophagus. A scintigraphic study was performed comparing the oesophageal transit of enteric coated tablets with similar sized and shaped gelatin capsules, using a population of elderly healthy volunteers similar in age (50-79 years) to the population most likely to be receiving regular treatment. Twenty three volunteers injested the radiolabelled tablet or capsule with 50 ml of water while sitting on two separate occasions according to a randomisation schedule. Oesophageal transit was assessed by gamma scintigraphy. Gastric residence was also assessed in 11 of 23 subjects. While the tablet was readily cleared from the oesophagus, mean transit time 4*3 seconds (range 1.0-14-0), the capsule often showed a comparatively prolonged holdup, mean transit time 20-9 seconds (range 1.5-174.5). Ten of 11 tablets emptied from the stomach intact, while all 11 capsules broke up in the stomach. Gelatin capsules showed a clear tendency to remain within the oesophagus of healthy elderly volunteers, while similar sized enteric coated tablets did not. These studies show the importance of assessing oesophageal transit when designing the formulation of drugs with a potential for oesophageal injury.
capsule often showed a comparatively prolonged holdup, mean transit time 20 -9 seconds (range 1.5-174.5). Ten adhere to oesophageal mucosa once they start to take up water. We therefore set out to compare the oesophageal transit of two formulations, one an enteric coated tablet and another a similar sized, filled gelatin capsule. As patients receiving regular treatment are usually elderly we chose a group of healthy elderly volunteers to assess the effect of formulation on oesophageal transit.
Methods

FORMULATIONS
Placebo tablets and capsules were supplied by Procter and Gamble Pharmaceuticals. The dosage forms were enteric coated tablets and #3 hard gelatin capsules containing enteric coated beads. The tablets were modified oval shaped (5-7X 1 l-5 mm) weighing 240 mg with a density of 1-2 g/cc. The enteric coating consisted of a Eudragit L100-55 (Rohm Pharma, Darmstadt, West Germany) polymer system with an average film thickness of 50 microns. The #3 gelatin capsules contained roughly 400 enteric coated 20/25 mesh Nu-Pareil beads (Crompton & Knowles, Fairlawn, NJ) coated with the same Eudragit L100-55 polymer system with an average film thickness of 40 microns. The density of the filled capsule is 0-6 g/cc.
Placebo formulations were prepared because it is the exterior of the dosage form that affects adhesion and elimination of the drug simplified the execution of the study. Condensed image display Figure 1 : The condensed image is generatedfrom each frame in the sequence of images. By summing all the counts in the x direction in the image matrix and putting the result in one pixel with the x coordinate corresponding to the frame number the condensed image may be generated. Each column therefore represents one frame in the study, the final image displaying the vertical position ofthe activity (y axis) against time (x axis).
RADIOLABELLING
exchange resin IRA 416 (Cl), particle size 0-3-1 2 mm (BDH Laboratories Lot 0293140K). The mixture was then dried in a glass beaker using a hot air dryer.
Tablets
The tablets were clamped and drilled at one edge using a 1-5 mm diameter drill bit sterilised with alcohol. Radiolabelled Twenty three volunteers aged 50 years or over were recruited from the surrounding population of Nottingham. The mean age of the subjects was 66 years (range 50-79). Table I gives the details of volunteers. During the two weeks before the trial and immediately after completion of the study all subjects had a medical examination. Subjects were divided into four groups and dosed according to a random schedule. A minimum period of three days was permitted between each investigation.
The study was approved by the hospital ethical committee and the Administration of Radioactive Substances Advisory Committee (ARSAC) of the UK Department of Health. All subjects were fully informed of the procedure and gave written consent to participate.
STUDY PROCEDURE
The volunteers arrived on each of the study mornings having fasted from 2200 the previous evening. At 0800 each subject was given a light breakfast of two slices of buttered toast and tea with milk. In strict order commencing at 1100 the subjects were seated in front of the gammacamera to facilitate anterior imaging. In each case the subject received the dosage form with 50 ml water taken in a continuous sequence of swallows. The images were recorded in a 64X64 cell matrix, over a total imaging time of 10 minutes as follows: (a) 60 dynamic frames (2 frames per second), (b) 38 dynamic frames (1 frame per 15 seconds).
Gastric emptying of the dosage forms was assessed in the first 11 consecutive volunteers. External radioactive markers were then taped to the anterior and posterior abdomen to permit accurate alignment of the subsequent sequential static images. Anterior and posterior placing all columns of data in sequence the condensed image is produced. Figure 1 gives a schematic diagram of the production of the condensed images. Anterior and posterior static images of the gastric activity were displayed and emptying was assessed by experienced operators (PEB and ACP) after defining a region of interest over the stomach and recording counts from the images. All data were corrected for radionuclide decay, background subtracted, and a geometric mean value calculated according to the method of Hardy and Perkins. 7 The time of break up of the formulation was noted, together with the time at which the unit or greater than 50% of the unit left the stomach.
Results
A total of 46 oesophageal transit studies were carried out. No adverse reactions or events were reported. All the volunteers swallowed the units with the 50 ml of water provided. There were no requests for additional water. None of the subjects complained of any discomfort or problem in swallowing any of the units. Volunteers were not aware of the data at any time. The subjects were therefore ignorant of any dysmotility that occurred. Tables II and III show the results of the transit and site of break up of the formulations. Of the 23 tablet studies the mean transit time was 4-3 seconds with a range of 10 to 14 seconds (sample standard deviation 2-9 seconds). Of the 23 capsule studies the mean transit time was 20-9 seconds with a range of 1-5 to 174-5 (sample standard deviation 35 6). A statistical analysis was conducted to quantify the degree of difference between the two formulations. For each formulation, subjects were classified as having oesophageal adhesion or not, depending upon whether the oesophageal transit time was greater than 20 seconds. Oscillatory motion (seven studies) -oscillation in the upper-mid oesophagus was visualised in four studies and oscillatory motion in the lower oesophagus was seen in three studies.
Oesophageal stasis (18 studies) -stasis was seen in the upper oesophagus in three studies, the mid oesophagus in nine studies, and the lower oesophagus in six studies.
From the gastric emptying data given in Table III it can be seen that one of the 11 tablet preparations broke up in the stomach before emptying. The gastric images of the 11 subjects when receiving the capsule preparations showed that the capsule broke up within the stomach in every case. The mean emptying half time (50% or greater) for the tablet preparation was 19 minutes (range 11-96). The 50% emptying time for the capsule preparations was 33 minutes (range 22-51).
Discussion
Radiographic studies and endoscopy have previously been used to examine the pathology of oesophageal injuries. Previous fluoroscopic studies9 have been performed to assess the oesophageal transit of tablets and capsules given orally but, in such instances although the shape and size of the preparation was unaltered for this study, the addition of barium sulphate granulate affected the density of the formulation. Such a change in density would therefore affect the alimentary transit of the units. Scintigraphic studies of the oesophageal transit of liquid and solids provide a more physiological means of assessing oesophageal transit and can show oesophageal spasm, stasis, and gastric reflux.'1013 Oesophageal transit is a routine clinical procedure in nuclear medicine departments, the method being noninvasive and with minimal discomfort to patients. A logical extension of this diagnostic procedure is to assess the transit of radiolabelled tablets and capsules and for all such studies it is essential that the radiolabelling does not adversely affect the contact surface properties of the preparation. Similar methods have been used to examine the influence of posture and coadministration of water.14 The results show some unexpected findings concerning the oesophageal transit of the formulations studied. Oesophageal stasis with complete dissolution of preparation has been previously seen in some studies but this phenomenon did not occur in this study. The transit seen suggested a degree of oesophageal dysfunction with some of the capsule preparations, though volunteers were initially screened and those with clinically apparent oesophageal dysmotility were excluded. The condensed image display was especially helpful in evaluating the transit of the preparations in each case. It is significant that the capsule was slow to clear in 22% of the studies, according to the mutually agreed preset criterion that oesophageal transit times of 20 seconds or greater would be taken as an indication of 1366 [ ! adhesion. The 20 second limit is less, however, than that used in other published studies15 16 where 60 and 90 seconds have been taken as the upper limit. In our experience, using scintigraphic studies, normal swallowing occurs within this shorter time period. Irrespective of the cut off used, the clear difference in the transit times measured between the tablets and capsules in this study remains apparent.
The tablets and capsules used in this study were of similar size and shape (the tablets being ovoid), however, as the capsules were only half the density of the tablets this may in part account for the differences seen in the comparative transit times of the two formulations. It is not possible, therefore, to conclude from this study whether the slower transit of the capsules was caused by oesophageal adhesion, or merely lack of propulsion because of the lower density of the units. The method of dosing is also extremely important. Drinking the water in a continuous sequence of swallows or alternatively by pausing between swallows may lead to different peristaltic contractions and hence a different pattern of transit. This study was performed in a standard manner with subjects swallowing in a continuous sequence of swallows.
The site of dysmotility seen in this study was mainly in the mid to lower oesophagus, this being consistent with other reported studies of oesophageal transit.5 Failure of propulsion in the distal oesophagus has also been noted in patients with non-specific motility disorders. The peristaltic wave tends to travel part of the way down the oesophagus and then to fail to progress, the most common site of failure being just below the aortic arch.17 Peristaltic dysfunction with hypotensive peristalsis in the distal oesophagus has also been seen in patients with overt reflux.I8 The prolonged residence of the capsules in the distal oesophagus is probably related to minor subclinical impairment of propulsion as well as the mucous adhesion properties of the capsule surface. It may be that the 'stickiness' of the gelatin capsule is related to the moisture content in the saliva, thus accounting for the differences between normal subjects.
In addition to the impaired propulsion seen with the capsules it is important to consider the consequences of the break up of the formulation within the stomach, a feature that was seen in all 11 subjects on swallowing the capsules and only one subject swallowing the tablet. The significance of this finding is uncertain because the method of manufacture may affect the disintegration characteristics of the units. In the case of the capsules the radiolabelling and manufacturing procedure should not affect the disintegration characteristics, but this may not be the case for the tablets as these had been drilled and plugged. In one subject the capsule was seen to break up before entering the stomach. This was seen on the condensed image as a double diverging trace. Emptying of the contents of the capsule into the stomach would have the secondary problem of oesophageal injury should gastrooesophageal reflux occur. Although gastrooesophageal reflux was not seen in this study, the occurrence of this cannot be ignored in the design of formulations intended for elderly patients.
This study clearly shows the importance of the assessment of oesophageal transit of formulations of drugs with a potential for oesophageal injury.
